News Daily News Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1 Early data from the first phase III trial of Lilly’s triple agonist show reductions in weight and HbA1c for patients with type 2 diabetes. Caitlin E. Cox March 19, 2026
Presentation Cardiovascular Interventions 2025 Cardiology’s Evidence Crisis and What We Can Do About It Presenter: Robert W. Yeh November 14, 2025
Presentation Cardiovascular Interventions 2025 New Guidelines for IVUS: Finally, the Indication is 1A Presenter: Evan Shlofmitz November 12, 2025
Presentation ESC 2025 Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial Presenter: Robin Hofmann August 31, 2025
Presentation ESC 2025 Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk Presenter: Brian Bergmark August 30, 2025
Presentation TCT India 2025 Management in the ICU BEFORE high-risk PCI and/or shock Presenter: Vijay Chilakamarri July 25, 2025
News Daily News Several Factors Linked to Subsequent Events After TIA, Minor Stroke By Todd Neale March 23, 2026
News Daily News Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race By L.A. McKeown March 23, 2026
News Daily News Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1 By Caitlin E. Cox March 19, 2026
News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide By L.A. McKeown March 19, 2026